Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Revenue (2016 - 2025)

Historic Revenue for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $1.2 million.

  • AC Immune's Revenue fell 9600.94% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 8297.13%. This contributed to the annual value of $31.2 million for FY2024, which is 8682.65% up from last year.
  • According to the latest figures from Q3 2025, AC Immune's Revenue is $1.2 million, which was down 9600.94% from $1.6 million recorded in Q2 2025.
  • AC Immune's Revenue's 5-year high stood at $29.4 million during Q3 2024, with a 5-year trough of -$163504.1 in Q1 2022.
  • Moreover, its 5-year median value for Revenue was $197132.4 (2021), whereas its average is $2.1 million.
  • As far as peak fluctuations go, AC Immune's Revenue plummeted by 749129.15% in 2022, and later surged by 9982869.04% in 2024.
  • Over the past 5 years, AC Immune's Revenue (Quarter) stood at $187618.9 in 2021, then skyrocketed by 289.5% to $730767.3 in 2022, then crashed by 95.99% to $29311.2 in 2023, then soared by 4328.03% to $1.3 million in 2024, then dropped by 9.56% to $1.2 million in 2025.
  • Its Revenue was $1.2 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.1 million in Q1 2025.